Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Subjects: BACTÉRIAS GRAM-NEGATIVAS, CHOQUE SÉPTICO
ABNT
SOUZA, Vanessa Kasubeck de et al. Does the amikacin effectiveness is reached in septic critically ill patient after the empirical daily dose against gram-negative mic 32mg/l strains?. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 14 nov. 2024. , 2017APA
Souza, V. K. de, Silva Júnior, J. M. da, Campos, E. V., Oliveira, A. M. R. R. de, Gomez, D. de S., Silva Junior, C. V. da, & Santos, S. R. C. J. (2017). Does the amikacin effectiveness is reached in septic critically ill patient after the empirical daily dose against gram-negative mic 32mg/l strains? Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Souza VK de, Silva Júnior JM da, Campos EV, Oliveira AMRR de, Gomez D de S, Silva Junior CV da, Santos SRCJ. Does the amikacin effectiveness is reached in septic critically ill patient after the empirical daily dose against gram-negative mic 32mg/l strains? Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 56 res. FCF108.[citado 2024 nov. 14 ]Vancouver
Souza VK de, Silva Júnior JM da, Campos EV, Oliveira AMRR de, Gomez D de S, Silva Junior CV da, Santos SRCJ. Does the amikacin effectiveness is reached in septic critically ill patient after the empirical daily dose against gram-negative mic 32mg/l strains? Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 56 res. FCF108.[citado 2024 nov. 14 ]